Work

A phase II study of nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer (mTNBC).

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.tps1119

Authors: Romualdo Barroso-Sousa, Hao Guo, William Thomas Barry, Grace Winship, Beth Overmoyer, Dan G. Duda, Sara M. Tolaney

Institutions: Dana-Farber Cancer Institute, Massachusetts General Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2806291464

Cites:

Cited by: 2

Related to: 10